CD56+-T-cell responses to bacterial superantigens and immune recognition of attenuated vaccines

Area of Science:

• Immunology
• Cell Biology

Background:

• Natural killer T (NKT) cells, expressing both natural killer (NK) and T-cell receptors (TCR), are crucial for immunity against viruses, tumors, and parasites.
• A known NKT cell subset utilizes biased TCRs to recognize glycolipids presented by CD1d, such as alpha-galactoceramide.
• However, a distinct population of human T cells coexpresses CD56 and unbiased TCRs, potentially engaging in antigen presentation independent of CD1d.

Purpose of the Study:

• To investigate the role of major histocompatibility complex (MHC) class II molecules in the activation of human CD56+ T cells.
• To determine the antigen presentation pathways utilized by these CD56+ T cells.

Main Methods:

• Activation of human peripheral blood mononuclear cells (PBMCs) using bacterial superantigens presented by MHC class II molecules.
• Analysis of CD56+ T cell frequencies and phenotypes (CD4, CD8 coreceptor expression).
• Assessment of cytokine expression profiles and response to pathogen-associated antigens (Staphylococcus aureus vaccine, tetanus toxoid).

Main Results:

• Activation with bacterial superantigens presented by MHC class II molecules led to an increased frequency of CD56+ T cells.
• CD4+ T cells within the CD56+ population were the primary responders to superantigens, exhibiting a Th1-like cytokine profile.
• Elevated levels of CD56+ T cells were observed in response to Staphylococcus aureus vaccine and tetanus toxoid antigens.

Conclusions:

• Human CD56+ T cells, characterized by unbiased TCRs and CD4/CD8 coreceptor expression, can recognize pathogen-associated ligands.
• This recognition appears to be mediated through major histocompatibility complex (MHC) class II molecules, distinguishing them from CD1d-restricted NKT cells.
• These findings suggest a significant role for MHC class II-restricted CD56+ T cells in adaptive immunity against microbial pathogens.